iNKT cells can be activated by a number of glycolipid ligands presented in the context of CD1d, such as that derived from Borrelia burgdorferi or the marine spongederived, -galactosylceramide (-GalCer) (3) (4) (5) (6) (7) (8) . In addition to TCR-mediated recognition of glycolipids, iNKT cells can be activated indirectly by stimulatory cytokines that are released by dendritic cells (DC) following toll-like receptor (TLR) signalling (i.e. interleukin (IL)-12 and type-1 interferons) (7, (9) (10) (11) . The activation of iNKT cells by -GalCer (3) has been shown to result in the release of a plethora of cytokines (such as IL-2,-3,-4,-6,-9,-10,-17,-21,GM-CSF,IFN and TNF) within hours of TCR ligation (12) supporting a potential role for these cells in contributing to the local cytokine milieu thereby impacting adaptive immune responses. The importance of iNKT cell activation and cross-talk between innate and adaptive immunity was demonstrated in early studies using -GalCer which identified a role for iNKT cells in tumour surveillance (3) . In addition to mediating tumour immunosurveillance, iNKT cells have been implicated in preventing autoimmune diseases (22) and aiding the clearance of pathogens (23) have been found in other models where anti-CD154 mAb was used to induce tolerance to cardiac and islet allografts (25, 26) . It is also worthwhile noting that 5 iNKT cells have also been shown to be involved in the rejection of allogeneic (27) and destruction of syngeneic islets (28) .
We and others have proposed that the microenvironment created by transplantation, incorporating inflammation generated by surgical trauma and ischemia as well as the induction of conventional alloresponses at sites of T cell priming and within the allograft itself, may promote iNKT cell activation (26, 29, 30) . In support of this, Li and colleagues demonstrated that following ischemia-reperfusion-injury to the kidney, iNKT cells rapidly infiltrated the kidney, increasing the production of IFN and promoting the recruitment of neutrophils; a process that was significantly reduced in iNKT -/-mice (31). Likewise, iNKT cells have been shown to expand in draining lymph nodes following allogeneic but not syngeneic skin transplantation (29) .
However, despite numerous reports implicating iNKT cells in transplant rejection and tolerance, little is known regarding how such cells are activated in this setting.
Here we show that murine iNKT cells bear no intrinsic reactivity to allogeneic cells.
Rather, iNKT cells undergo proliferation and secrete cytokine following bystander activation as a result of IL-2 produced by alloreactive T cells following activation. 
Skin Transplantation
Individual full-thickness tail skin grafts were prepared to fit the graft bed on the left lateral thorax of anesthetized recipients. The grafts were inspected regularly and harvested at day 10 post transplantation for analysis.
Flow Cytometry, Antibodies and Tetramer staining
Cell sorting and analysis was performed on a FACSAria, and flow-cytometric analyses were performed using FACS DIVA software (BD Biosciences, UK). All antibodies used in flow cytometry were purchased from BD PharMingen or eBioscience. Anti-CD1d mAb (3CII) was a kind gift from Dr J. Yewdell (NIH, Bethesda, Maryland, USA). CD1d tetramer conjugated with APC was provided preloaded with PBS-57 (National Institutes of Health (NIH) Tetramer Facility, Atlanta, USA). PBS-57 is an analogue of -GalCer and CD1d-PBS57 tetramers stain iNKT cells comparably to CD1d-GalCer tetramers (ProImmune, UK). To determine cell numbers by flow cytometry, a fixed number of 6μM synthetic fluorescent beads (BD Biosciences, UK) were added, as detailed previously (32) .
Purification of NKT cells
Splenocytes were incubated with in house produced rat anti-mouse mAb specific for For the in vivo proliferation assay iNKT-RAG mice were generated (S1). Briefly, iNKT cells were cell sorted by FACS twice using splenocytes derived from MHCII -/-using CD1d-PBS57 loaded tetramer and CD5 mAb to a purify exceeding 99.7%. 
Real-time PCR
Skin grafts were harvested at day 10 post transplant and snap frozen. DNase Itreated total RNA was later isolated by using the Absolutely RNA Miniprep kit (Stratagene, UK) and reverse-transcribed by the M-MLV reverse transcriptase (Invitrogen, UK) as previously described (33) . Real-time quantification was performed by using the PRISM 7700 sequence detection system (AppliedBiosystem, UK) using a fluorogenic probe as described previously (33) . Specific primers and probes for HPRT and V14J218 were used as previously described (26, 33) .
Samples were standardised for HPRT and quantification of the gene of interest calculated as previously described (34) .
ELISA
ELISA were conducted in 96 well Maxisorp plates (Nunc, Denmark) and analysed using an Emax precision microplate reader (Molecular Devices) and Softmax software (Molecular Devices). Samples and doubling dilutions of IFN- standards (BD Pharmingen) were analyzed in triplicate. IFN- capture mAb (R46A2) was grown and purified in the laboratory. IFN- was detected using a biotin-labelled 10 anti-IFN- mAb (XMG1.2; BD Pharmingen) and developed using avidin HRP (Vector Laboratories) followed by ABTS substrate and hydrogen peroxidise (Sigma, UK).
Cytokine Bead Array
Cytokine bead array kits were used to detect Th1 and Th2 associated cytokines (IL-2, IL-4, IL-5, IFN-, TNF) following the manufacturer's protocol (BD Biosciences, UK).
Samples were acquired on a FACS Aria (BD Biosciences, UK).
Statistical analysis
All statistical analyses were performed using Graphpad Prism software version 4.0.
The Student's t test with two-tailed analysis was used to compare the level of significance between data sets. All p values <0.05 were considered significant. Figure 3B ). It remained possible that TEa T cells expressed CD1d and therefore provided a source of TCR-mediated recognition for the iNKT cells.
However, this was ruled out as CD1d was not detected on TEa T cells ( Figure 3A) .
Activated alloreactive T cells facilitate iNKT cell activation in vivo.
Thus far we have shown in vitro that upon co-culture with allogeneic stimulators iNKT cell proliferation was markedly increased when both conventional T cells and iNKT cells were responding in concert. Next, we examined whether these findings could be recapitulated in vivo by adoptively transferring TEa T cells to either 
Conventional T cell-derived IL-2 mediates bystander activation of iNKT cells
In order to examine the mechanism by which activated alloreactive T cells (TEa) facilitate iNKT cell expansion in vitro and in vivo we tested whether this form of TEa T cells cultured with stimulators were found to produce IL-2 on day 2, which was further increased by day 3 ( Figure 5B ). In comparison, when TEa T cells were cultured with stimulators and iNKT cells, IL-2 levels were significantly reduced and no different from negative control cultures which is consistent with sequestration of IL-2 by iNKT cells. We tested whether adding exogenous IL-2 would also result in the proliferation and expansion of iNKT cells given that even in a resting state, iNKT cells express all constituent subunits of the IL-2 receptor-complex ( Figure 5C ). The addition of IL-2 was found to drive iNKT cell expansion in a dose-dependent manner ( Figure 5D ). Interestingly, the expression of the high affinity -subunit of the IL-2 receptor, CD25, was greatly increased when iNKT cells were cultured with either exogenous IL-2 or TEa T cell supernatant, suggesting that iNKT cells operate the same positive feedback loop for IL-2-IL-2 receptor expression as has been reported for conventional T cells (36) . Importantly, in the presence of anti-CD25 blocking mAb, iNKT cells fail to proliferate and expand when cultured in supernatant derived from TEa T cells cultures with stimulators ( Figure 5F ).
Bystander activation of iNKT cells results in cytokine secretion.
The rapid production of cytokines is one of the hallmarks of iNKT cell activation. 
Having shown that iNKT cells proliferate and expand in vitro and

Discussion
The activation of iNKT cells has largely focused on endogenous and exogenous ligands, presented in the context of CD1d. In this study we describe an alternative mechanism of iNKT cell activation which operates independently of CD1d, following the activation of conventional T cell by alloantigen.
We were unable to show that murine iNKT cells harbour alloreactivity ( Figure 1B) and only one publication using human cloned iNKT cells has shown proliferation to allogeneic but not autologous monocytes, in a TCR dependent manner (37) . It remains unclear whether this is a feature of cloned human iNKT cells and what glycolipid (if any) is being presented by allogeneic but not syngeneic CD1d molecules to drive the iNKT cell response. In contrast to these findings, in mouse models of skin transplantation, iNKT cells have been shown to proliferate in the draining lymph node following sex-mismatched but not syngeneic grafts and were also found within the allografts (29) . Indeed, we have confirmed these finding using fully MHC mismatched skin allografts (S3). Importantly, such responses occurred independently of donor CD1d suggesting that murine iNKT cells have no direct TCR-mediated alloreactivity and that the microenvironment following transplantation provides the dominate signal for iNKT cell activation (29) . We investigated this possibility in vitro and demonstrated that despite the lack of evidence supporting direct iNKT cell activation following recognition of allogeneic cells, co-culture of iNKT cells with alloreactive TEa T cells was found to drive iNKT cells to proliferate both in vitro (Figure 1-2 ) and in vivo ( Figure 4 ) and was associated with secretion of effector cytokine (IFN; Figure 6 ). This is likely to have been produced by iNKT cells, since even after 3 days culture in the absence of iNKT cells, stimulated TEa T cells produced only low levels of IFN typical of the lag in effector cytokine secretion seen upon stimulation of naive T cells ( Figure 6A ). In support of this, the production of IFN was found to be directly correlated with iNKT cell number ( Figure 6B ) and replicated when iNKT cells were cultured alone in the presence of supernatant from TEa T cells and stimulator, removed after 2 days of culture ( Figure 6C ).
Collectively, to our knowledge, this is the first example, in the absence of exogenous synthetic ligands, to show that iNKT cells can become activated, expand and secrete cytokine as an indirect consequence of an adaptive immune response. Given the lack of requirement for CD1d-TCR mediated recognition for iNKT cell responses in this setting (Figure 3, S2) , we propose that the production of IL-2 by activated alloreactive T cells drives iNKT cell activation and effector function following transplantation. Interestingly, this mechanism of iNKT cell expansion has been reported using experimental IL-2-mAb-immunocomplexes (38) and as a side effect of IL-2 therapy, for the treatment of HIV-1 patients (39).
In the context of transplantation, we and others have proposed that the cytokine milieu at the site of T cell priming is more important for the activation of iNKT cells than their activation through specific TCR-mediated interactions (26, 29, 30) . These data provide one possible explanation of how iNKT cells are activated following transplantation, i.e. through bystander activation as a result of a conventional T cell response to alloantigen. Once activated, iNKT cells may in turn be able to contribute to and influence the local cytokine microenvironment which may be either detrimental or beneficial to transplant survival, since iNKT cells can produce a plethora of both pro-and anti-inflammatory cytokines upon activation (30) . However, in other instances the production of IFN by iNKT cells has been shown to be required for transplant tolerance of cardiac and islet allografts (24).
As we have shown that iNKT cells can be activated and produce IFN following conventional T cell alloresponses, it is tempting to speculate that this mechanism of activation may promote the induction of regulatory mechanisms. Although, IFN is classically thought of as a pro-inflammatory cytokine we and others have shown that the production of IFN is essential for the function of regulatory T cells (Treg) and that IFN can be immunosuppressive under certain circumstances (45, 46) . 
Description of Supporting Information:
The supporting information is composed of three additional figures (S1, S2 and S3).
In S1 we provide information for the development of the iNKT-RAG model. In this model we demonstrate the successfully generation of RAG deficient mice (i.e. lacking T and B cells) that can be seeded with a population of iNKT cells. In S2 we show that the proliferation and expansion of iNKT cells to IL-2 does not require CD1d-TCR interactions. In S3 we confirm the previously published finding of Oh et al that iNKT cells expand in lymph nodes that are draining alloantigen following skin transplantation and traffic to allogeneic but not syngeneic skin grafts (29) .
However, we have included this figure as we are using a different strain of donor.
Oh et al performed skin transplantation between C57 BL/6 and sex-mistmatched recipients, whereas in S3 we are using major-MHC-mismatched donors (BALB/c).
